New HCPCS Codes for COVID-19 Treatments
New HCPCS Codes for COVID-19 Treatments On June 24, the Food and Drug Administration (FDA) released an Emergency Use Authorization for tocilizumab (Actemra), a monoclonal antibody product used for the treatment of COVID-19. Providers should use the following new HCPCS Level II codes when billing this product: Q0249 Injection, tocilizumab, for hospitalized adults and pediatric patients (2 … Read more